Prehabilitation in Patients With Advanced Stage Ovarian Cancer Planned for Interval Debulking Surgery

  • STATUS
    Recruiting
  • End date
    Jun 1, 2022
  • participants needed
    25
  • sponsor
    Charles University, Czech Republic
Updated on 16 March 2021

Summary

There is a strong evidence of positive effect of multimodal prehabilitation from prospective controlled trials among patients treated surgically for non-gynaecological cancer. However, the number of studies published on prehabilitation programs in gynaecologic surgery are limited, especially in gynaecologic cancer patients. No study or trial comprehensively evaluating a prehabilitation pathway for patients with extensive ovarian cancer has been published so far.

Description

The protocol summary and informed consent form will be made available on clinicaltrials.gov when required.

Details
Condition Ovarian disorder, Ovarian Cancer, Ovarian Function, Stage IV Ovarian Epithelial Cancer, Ovarian Cancer Stage III, Ovarian Cancer Stage IV, Recurrent Ovarian Cancer, ovarian carcinomas, cancer, ovarian, cancer ovarian, cancer of the ovary, ovarian tumors
Treatment psychological intervention, nutritional intervention, Physiological intervention
Clinical Study IdentifierNCT04789694
SponsorCharles University, Czech Republic
Last Modified on16 March 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Epithelial ovarian cancer
FIGO stage III or IV disease
Patient is not a candidate for primary debulking surgery
Patient is a suitable candidate for standard of care combined chemotherapy
Patient is a candidate for interval debulking surgery

Exclusion Criteria

Non-epithelial ovarian cancer
Extraovarian tumor
Second malignant tumour (under the treatment)
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note